Dr. Weil says there’s a better approach to evaluating clinical drug trials

Dr. Andrew Weil, among the best-known medical doctors practicing alternative and complementary medicine, suggests researchers are ignoring an important endpoint when they evaluate the success or failure of clinical drug trials: how the patient feels about the treatment.

Medicine has become enslaved to “evidence-based” approaches that rely on randomized, clinical trials as the only measure of whether a treatment is valuable, Weil and his co-authors wrote. While these gold-standard studies are vital, they are not the only way to measure worth, they said.

Read more at: http://www.latimes.com/health/boostershots/la-heb-alternative-medicine-20110512,0,1037141.story

Comments are closed.